SPARC partners with UCSF and Tiller Therapeutics to license oncology asset EP News Bureau Dec 17, 2024 Agreement grants SPARC equity in Tiller for development and commercialisation of joint oncology intellectual property
SPARC enters into licensing deal with CMS to develop and commercialise products EP News Bureau Nov 6, 2019 The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…
